(NASDAQ: RDNT) Radnet's forecast annual revenue growth rate of 11.16% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 11.6%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 19.19%.
Radnet's revenue in 2025 is $1,772,946,000.On average, 3 Wall Street analysts forecast RDNT's revenue for 2025 to be $145,897,815,419, with the lowest RDNT revenue forecast at $144,648,244,098, and the highest RDNT revenue forecast at $148,066,058,545.
In 2026, RDNT is forecast to generate $155,069,728,133 in revenue, with the lowest revenue forecast at $154,535,255,092 and the highest revenue forecast at $155,604,201,174.